Status:
COMPLETED
Oligodendrocyte Progenitor Cell Culture From Human Brain
Lead Sponsor:
Department of Medical Services Ministry of Public Health of Thailand
Conditions:
Demyelinating Diseases
Eligibility:
All Genders
20-65 years
Phase:
PHASE1
Brief Summary
Recent developments in the understanding of stem- and progenitor cell differentiation raises hopes that brain damage in chronic neurological diseases may become repaired by systemic or focal transplan...
Detailed Description
Oligodendrocyte progenitor cell line were cultures and will be transplanted into the patient with Multiple sclerosis.
Eligibility Criteria
Inclusion
- Male or female 20-65 years of age
- Informed consent
- Has elective craniotomy surgery
Exclusion
- HIV, hepatitis, and other central nervous system (CNS) infections
- Dementia, Alzheimer disease, and neurodegenerative disease
Key Trial Info
Start Date :
December 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00283023
Start Date
December 1 2007
End Date
December 1 2010
Last Update
October 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistant Professor Subsai Kongsaengdao
Bangkok, Thailand, 10400